HELIOS-A: 9-Month Results from the Phase 3 Study of Vutrisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
AuthID
P-00V-FMA
P-00V-FMA
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service